Search

Connect (X) hosts the end-to-end 5G supplier ecosystem from the ground up. Every segment of the industry is represented at Connect (X) — united under one roof to engage with the latest thinking, experience the newest solutions, and connect with new partners—all with the goal of fulfilling the...

This checklist highlights certain considerations for companies preparing to file annual reports on Form 10-K for the calendar year ended 2023 and is intended to serve as a focused resource highlighting changes in disclosure requirements and points of emphasis for the Securities and Exchange...

PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...

The use of artificial intelligence (AI) in health care, and specifically, as the utilization of software in medical devices continues to increase. Machine learning (ML) is a branch of AI in which computer systems automatically adapt, improve, and make predictions by applying algorithms to analyze...

Kathryn Doyle, a partner at Saul Ewing, will present during the Penn Medicine Commercialization Speaker Series. She will discuss the latest trends in Life Sciences intellectual property on November 17 from 12:00 - 1:00 p.m.

A Decade Later, Section 6409 is Still Facilitating Wireless Deployments Rapisarda provides consultation, legal advice, and strategy relating to all aspects of wireless infrastructure development. He works with carriers, tower companies and vendors on all land use, zoning, permitting, and related...

Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...

Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...

Jeffrey Hampton is chair of the Bankruptcy and Restructuring Practice. He concentrates his practice on restructuring matters, including Chapter 11 bankruptcy proceedings, out-of-court workouts, loan restructurings, corporate reorganizations and general insolvency law. He also represents the...

Colleen Foley has more than two decades of experience handling a wide range of regulatory matters for public utilities and energy companies, including representing clients in nearly every major utility merger in New Jersey over that time span. Her work includes representations of water...

A life sciences patent attorney with a Ph.D. in virology and cell and molecular biology, Kathryn Doyle represents universities and companies throughout the United States in identifying, protecting and enforcing their intellectual property in the areas of biotechnology, pharmaceuticals, agriculture...

Gianna Arnold helps companies protect, leverage and enforce their intellectual property and develop and memorialize strategic alliances in service to their goal of enhancing their value. Her understanding of the importance of these assets to the bottom line of a business stems in part from her past...

Wendie Stabler provides trusted legal counsel to clients across the country on commercial real estate deals (including leases, dispositions and acquisitions) as well as developments, redevelopments and expansions. Wendie's legal work also includes a wide array of projects promoting sustainable...

Eric Orlinsky co-chairs the firm's Corporate Practice and its Private Equity/Venture Capital subgroup and concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity...

Mark Simpson counsels technology and intellectual property innovators to assist them in developing, protecting, and monetizing the results of their creative endeavors, with a focus on IP strategy and branding. He protects their IP assets via patent preparation and prosecution, IP counseling and...

Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...

Justin C. Danilewitz draws upon his trial and investigative experience as a former federal prosecutor to zealously defend entities and individuals facing criminal and civil enforcement actions, conduct internal investigations, and respond to whistleblower complaints and false claims (qui tam) suits...